18th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
March 3-5, 2019 • Chicago, IL

<< BACK TO POSTERS

  |  A Quality Improvement Project to Ensure Timely Cytomegalovirus Testing and Follow Up for Babies that Do Not Pass Newborn Hearing Screening at Mayo Clinic

A Quality Improvement Project to Ensure Timely Cytomegalovirus Testing and Follow Up for Babies that Do Not Pass Newborn Hearing Screening at Mayo Clinic

Twenty-six percent of babies diagnosed as deaf or hard of hearing show evidence of cytomegalovirus (CMV) infection. CMV is a virus that infects people of all ages. Most people show no symptoms of having been infected. CMV can pose serious health problems to a baby if the mother is infected while pregnant. Some of the consequences of congenital CMV may have long term health problems. Minnesota, like most states, does not have established clinical practices to have CMV testing performed on babies who do not pass their initial newborn hearing screening. Mayo Clinic and Mayo Clinic Health System are developing practice guidelines to identify and monitor babies who have CMV in the well child population. By 21 days of age, all babies will complete CMV testing by urine or saliva using polymerase chain reaction (PCR) testing if they do not pass the second (in hospital) newborn hearing screen. If a specimen cannot be collected before discharge, primary care will be notified to accomplish this. The aim of this project is to develop a prospective protocol that includes all babies who do not pass newborn hearing screening and are CMV positive. These babies will go on to audiometric diagnostic evaluation and be referred to infectious disease specialists. All babies, regardless of their hearing status, will have regular audiometric follow up. As part of this project we will develop electronic medical record standards and clinical practice guidelines. Completion of this project will enhance early identification and management of babies who are deaf or hard of hearing as a result of CMV infection.

  • To develop a quality improvement strategy where all babies who do not pass hearing screening get CMV testing by 21 days of age
  • To develop a follow up plan for all babies who test positive for CMV
  • To create an electronic means of tracking these babies and to create a family centered educational tool

Presentation:
This presentation has not yet been uploaded or the speaker has opted not to make the presentation available online.

Handouts:
Handout is not Available

Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference


Presenters/Authors

Lee Belf (), Mayo Clinic Rochester, belf.lee@mayo.edu;
Lee received her B.A. and M.A. degrees at Western Michigan University. She received her Au.D. from University of Florida. Lee has been an audiologist at Mayo Clinic Rochester, MN since 1990 with her primary interest in Pediatric Audiology.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.


Joscelyn Martin (), Mayo Clinic Rochester, martin.joscelyn@mayo.edu;
Joscelyn Martin is a pediatric audiologist at Mayo Clinic in Rochester. She holds Pediatric Audiology Specialty Certification from the American Board of Audiology. She developed an interest in pediatric audiology while serving as a faculty member and preceptor at Northwestern University. She has been coordinator of the newborn hearing screening program at Mayo Clinic since its inception in 1999. In addition to newborn hearing screening, she is passionate about child and family centered counseling, and the positive effect that it has on the diagnostic and re/habilitative process for the families with whom she works.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.


Charles Huskins (), Mayo Clinic Rochester, huskins.charles@mayo.edu;
Dr. Huskins' research is focused on improving health care by studying interventions to prevent health-care-associated infections and to improve use of antimicrobial agents, which can lead to infections caused by antimicrobial-resistant bacteria.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.


Lisa Schimmenti (), Mayo Clinic Rochester, schimmenti.lisa@mayo.edu;
Dr. Schimmenti is a Senior Associate Consultant at Mayo Clinic in the departments of Otorhinolaryngology, Clinical Genomics and Biochemistry and Molecular Biology. She is the AAP Chapter Champion for Minnesota and the regional champion for Region VI. She has served on the Minnesota Department of Health Newborn Hearing Screening Committee for over a decade. Her basic science laboratory studies hearing and vision in zebrafish.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.


Gayla L. Poling (), Mayo Clinic, Rochester, MN, poling.gayla@mayo.edu;
Dr. Poling studied Audiology and Hearing Sciences at The Ohio State University. She joined in 2015 as Director of Adult and Pediatric Diagnostic Audiology at Mayo Clinic in Rochester and is an Assistant Professor of Audiology, Mayo Clinic College of Medicine. Her primary area of interest is auditory diagnostics across the life span with her research focus on early detection and prevention of hearing loss.

ASHA DISCLOSURE:

Financial - Receives Salary,Intellectual property rights for Employment from Mayo Clinic.   Receives Salary,Intellectual property rights for Employment from Mayo Clinic.  

Nonfinancial - No relevant nonfinancial relationship exist.